模型模拟在城市SO2环境容量测算中的应用研究

以许昌市污染源普查数据为基础,通过现状排放、环境质量控制目标与预测环境质量、污染物削减和浓度贡献分析,核定得到了准确可靠的许昌市二氧化硫环境容量;研究建立的从宏观理想容量到实际容量的多源模型体系,能较好地应用于二氧化硫环境容量研究;A—P值法、AERMOD模型均能较好地模拟污染源与环境空气质量的响应关系,且二者具有较好的一致性,可作为可靠的多源模型广泛应用于中小城市的二氧化硫环境容量核定研究及环境规划管理。     

A/O-MBBR工艺处理生活污水性能及菌群结构

采用设计规模为100m³/d的一体化缺/好氧-移动床生物膜反应器(A/O-MBBR)处理实际生活污水,通过265d的中试研究考察了该工艺在多因素扰动下的除碳和脱氮性能,并对不同运行阶段微生物群落结构的动态变化进行了研究.结果表明,一体化A/O-MBBR系统具有良好的COD去除效果和脱氮性能.当好氧池溶解氧(DO)浓度和进水碳氮比(COD/N)分别为2.5~3.5mg/L和(7.9±2.0)时,COD、NH₄⁺-N和TN去除率分别达到(93.3±5.4)%、(99.1±0.6)%和(67.9±10.5)%.Proteobacteria、Bacteroidetes和Chloroflexi在不同运行时期均有较高的相对丰度,保证了有机物的高效去除.A/O-MBBR系统脱氮功能菌在运行初期主要分布于活性污泥中,且相对丰度较低.长期运行后,生物膜与活性污泥中均同时检出大量硝化菌和反硝化菌.其中,相对丰度最高的硝化菌为Nitrospira,主要分布于生物膜上(19.48%~28.05%).反硝化菌则以Thauera、Terrimonas和Dokdonella等为主.     

A~2/O-MBR工艺在农村生活污水处理中的示范

A2/O-MBR工艺因其稳定的出水水质和良好的脱氮除磷效果,在我国城镇早已得到规模化应用。但在农村由于受各种条件制约,使该工艺的应用受到限制。通过A2/O-MBR工艺在四川农村地区散户的小规模示范,分析了其在污染物去除、建设、运行维护等方面的特点以及需注意的问题,为该技术在农村地区的推广应用做出积极的探索。     

光催化氧化技术降解水中双酚A的研究进展

目前环境雌激素双酚A(bisphenol A,BPA)所带来的危害已成为学术研究的热点问题。光催化氧化技术作为新兴的高级氧化技术,可快速降解水中双酚A。介绍了几种主要的光催化氧化技术降解双酚A的机理,并综述了国内外利用新型光催化剂在降解双酚A领域所取得的研究进展,为光催化氧化技术在双酚A降解领域的研究提供参考。     

河源城南污水处理厂尾水深度处理效果的研究

河源市城南污水处理厂利用垂直流人工湿地对该厂A2-O工艺处理的尾水进行深度处理,研究了人工湿地对尾水中TN、NH4+-N、TP、COD、BOD5的去除效果。结果表明:人工湿地对污水处理厂尾水具有较好的深度处理效果,垂直流人工湿地处理系统对尾水中TN、NH4+-N、TP、COD和BOD5平均去除率分别达到97.4%、97.8%、95.06%、91.87%和95.87%以上,其出水水质基本达GB 18918—2002《城镇污水处理厂污染物排放标准》一级A标准,地表水Ⅲ类标准。     

UASB+接触氧化法处理CMC废水

CMC废水属于高盐分高有机物废水,废水COD为50 000~80 000 mg/L,含盐量为13%左右,不适合直接生化处理。本文采用CMC废水和循环冷却水按一定比例混合后一起处理,混合后的废水采用UASB+接触氧化法的处理工艺处理。工程运行表明:稀释后的CMC废水中的盐分稳定在1.4%以内,该处理工艺能够确保出水达到《污水综合排放标准》(GB8978-1996)中三级排放标准。     

First trimester prenatal diagnosis of haemophilia A: Two years' experience

We evaluated the feasibility, reliability, and acceptability of prenatal diagnosis of haemophilia A by DNA analysis of chorionic villi. Twenty-two women at risk to transmit the abnormal gene were referred for prenatal diagnosis, two of them twice. Two of the 22 women appeared to be non-carriers by DNA analysis. In one of these women, the results were known only after chorionic villus sampling had been carried out. Thirteen of the twenty carriers were heterozygous for an intragenic (Bell or Xbal) marker; six women were only heterozygous for the extragenic DXS52 (Stl4) locus. One of the women was homozygous for all the presently known DNA markers within or closely linked with the factor VIII locus. Twelve of the 22 fetuses at risk were male, ten were female. Seven of the 12 male fetuses were shown to be affected and were subsequently aborted. Four male fetuses appeared to be not affected. In one case, the diagnosis was made by use of an extragenic marker. The woman rejected fetal blood sampling to confirm the diagnosis. After birth, a normal factor VIII level was found in three of the four cases. The fourth pregnancy is still continuing. In one of the 12 male fetuses, no diagnosis at the gene level was possible. DNA analysis is expected to provide maximum certainty as to the phenotype of the fetus for approximately 60 per cent of the women; for another 37 per cent a rate of misdiagnosis of 4–5 per cent applies. In only 3 per cent of the cases will no diagnosis at the gene level be possible as yet. The new possibility of a prenatal diagnosis in the first trimester of pregnancy enabled some of these women to have a family of their own and was appreciated in particular by the women who underwent fetoscopy in an earlier pregnancy.     

Prenatal diagnosis of the hurler syndrome: Report on 40 pregnancies at risk

In 40 pregnancies at risk for the Hurler syndrome 13 affected fetuses were detected by the demonstration of an α-L -iduronidase deficiency and an increased level of ³⁵S-sulphate incorporation. The diagnoses were confirmed by the analysis of fetal tissues and/or cultured fetal skin fibroblasts. Microassays for α-L -iduronidase, using phenyl α-L -iduronide and more recently 4–methyl-umbelliferyl α-L -iduronide, enabled a reliable diagnosis to be made within 15 to 18 days after amniocentesis. ³⁵S-sulphate incorporation has been a valuable adjunct in cases with a low (heterozygote) enzyme activity.     

水解酸化/催化铁耦合+A~2O工艺在镇江市新区第二污水厂的应用

镇江市新区第二污水厂采用水解酸化/催化铁耦合+A2O工艺,一期处理规模为2×104 m3/d,进水主要是新区化工园区的混合化工废水。文章详细介绍了该污水厂的工艺流程、相关设备及构筑物设计参数。运行结果表明,用水解酸化/催化铁耦合+A2O工艺处理混合化工废水,处理效果良好,出水水质基本达标。     

BPA和EE2在PA微塑料上竞争吸附的位点能量

为研究微塑料上雌激素共存的吸附行为,以17α-乙炔基雌二醇（EE2）和双酚A （BPA）为目标污染物,微塑料聚酰胺（PA）为吸附剂,通过等温吸附实验研究二者在单溶质和双溶质体系下的吸附性能,基于位点能量分布理论进一步剖析二者在PA微塑料上的的吸附特性.同时,采用X射线光谱（XPS）以及傅里叶变换红外光谱（FTIR）对吸附前后的PA微塑料进行表征,探究其可能存在的吸附机理.等温吸附拟合结果及XPS、FTIR的表征结果表明BPA和EE2及二者混合溶液在PA上的吸附属于非均质吸附,疏水分配及氢键作用为主要的吸附机制.位点能量分布分析结果表明,相同浓度（1～4mg/L）条件下,BPA吸附位点主要分布于高能量区;单溶质体系的EE2吸附位点主要集中于低能量区.双溶质体系下,相同浓度的两种物质位点分布函数均随着位点能量的增大而呈指数降低,BPA下降趋势较为平缓,吸附位点分布更集中.两种体系相比较,BPA平均位点能量和位点能量非均质性分别增加了0.749%和2.483%,吸附位点数量减少了10.852%;双溶质体系下EE2平均位点能量降低0.813%,位点能量非均质性增加1.870%,吸附位点数量增加42.429%.双酚A和EE2在PA微塑料上的竞争吸附中,EE2占优势.